82 related articles for article (PubMed ID: 31044025)
21. Constitutive Phosphorylation of STAT3 by the CK2-BLNK-CD5 Complex.
Rozovski U; Harris DM; Li P; Liu Z; Jain P; Veletic I; Ferrajoli A; Burger J; O'Brien S; Bose P; Thompson P; Jain N; Wierda W; Keating MJ; Estrov Z
Mol Cancer Res; 2017 May; 15(5):610-618. PubMed ID: 28130399
[TBL] [Abstract][Full Text] [Related]
22. Prognostic impact of CD5 expression in diffuse large B-cell lymphoma in patients treated with rituximab-EPOCH.
Thakral B; Medeiros LJ; Desai P; Lin P; Yin CC; Tang G; Khoury JD; Hu S; Xu J; Loghavi S; Hu B; Oki Y; Li S
Eur J Haematol; 2017 Apr; 98(4):415-421. PubMed ID: 28039906
[TBL] [Abstract][Full Text] [Related]
23. CCND1-IGH Fusion-Amplification and MYC Copy Number Gain in a Case of Pleomorphic Variant Mantle Cell Lymphoma.
Miao Y; Lin P; Wang W; Jeffrey Medeiros L; Lu X
Am J Clin Pathol; 2016 Dec; 146(6):747-752. PubMed ID: 28028120
[TBL] [Abstract][Full Text] [Related]
24. CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes.
Garaud S; Taher TE; Debant M; Burgos M; Melayah S; Berthou C; Parikh K; Pers JO; Luque-Paz D; Chiocchia G; Peppelenbosch M; Isenberg DA; Youinou P; Mignen O; Renaudineau Y; Mageed RA
Cell Mol Immunol; 2018 Feb; 15(2):158-170. PubMed ID: 27499044
[TBL] [Abstract][Full Text] [Related]
25. De-novo CD5 + B- prolymphocytic leukemia (PLL) presenting at younger age with favourable outcome.
Kar R; Kumar R; Tyagi S
Turk J Haematol; 2008 Sep; 25(3):149-51. PubMed ID: 27264708
[TBL] [Abstract][Full Text] [Related]
26. CD5 Binds to Interleukin-6 and Induces a Feed-Forward Loop with the Transcription Factor STAT3 in B Cells to Promote Cancer.
Zhang C; Xin H; Zhang W; Yazaki PJ; Zhang Z; Le K; Li W; Lee H; Kwak L; Forman S; Jove R; Yu H
Immunity; 2016 Apr; 44(4):913-923. PubMed ID: 27096320
[TBL] [Abstract][Full Text] [Related]
27. CD5 positivity is an independent adverse prognostic factor in elderly patients with diffuse large B cell lymphoma.
Chuang WY; Chang H; Shih LY; Wang PN; Chang YS; Lin TL; Hung YS; Yeh CJ; Ueng SH; Tang TC; Kuo MC; Dunn P; Wu JH; Kao HW; Ou CW; Wan YL; Hsueh C
Virchows Arch; 2015 Nov; 467(5):571-82. PubMed ID: 26369546
[TBL] [Abstract][Full Text] [Related]
28. CD5 as a Target for Immune-Based Therapies.
Consuegra-Fernández M; Aranda F; Simões I; Orta M; Sarukhan A; Lozano F
Crit Rev Immunol; 2015; 35(2):85-115. PubMed ID: 26351145
[TBL] [Abstract][Full Text] [Related]
29. De Novo CD5 Negative Blastic Mantle Cell Lymphoma Presented with Massive Bone Marrow Necrosis without Adenopathy or Organomegaly.
Elyamany G; Alzahrani AM; Al Mussaed E; Aljasem H; Alotaibi S; Elghezal H
Case Rep Hematol; 2015; 2015():146598. PubMed ID: 26347832
[TBL] [Abstract][Full Text] [Related]
30. Role of B cell receptor signaling in IL-10 production by normal and malignant B-1 cells.
Alhakeem SS; Sindhava VJ; McKenna MK; Gachuki BW; Byrd JC; Muthusamy N; Bondada S
Ann N Y Acad Sci; 2015 Dec; 1362(1):239-249. PubMed ID: 26096907
[TBL] [Abstract][Full Text] [Related]
31. Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries.
Xu-Monette ZY; Tu M; Jabbar KJ; Cao X; Tzankov A; Visco C; Nagarajan L; Cai Q; Montes-Moreno S; An Y; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Zhao X; Møller MB; Farnen JP; Winter JN; Piris MA; Miranda RN; Medeiros LJ; Young KH
Oncotarget; 2015 Mar; 6(8):5615-33. PubMed ID: 25760242
[TBL] [Abstract][Full Text] [Related]
32. CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases.
Li Y; Hu S; Zuo Z; Hong M; Lin P; Li S; Konoplev S; Wang Z; Khoury JD; Young KH; Medeiros LJ; Yin CC
Mod Pathol; 2015 Jun; 28(6):787-98. PubMed ID: 25743023
[TBL] [Abstract][Full Text] [Related]
33. Clinical and phenotypic features of CD5-negative B cell chronic lymphoproliferative disease resembling chronic lymphocytic leukemia.
Romano C; Sellitto A; Chiurazzi F; Simeone L; De Fanis U; Raia M; Del Vecchio L; Lucivero G
Int J Hematol; 2015 Jan; 101(1):67-74. PubMed ID: 25432435
[TBL] [Abstract][Full Text] [Related]
34. Aberrant Immunophenotypic Expression of CD5 in a Case of B Acute Lymphoblastic Leukemia: A Case Report.
Mutreja D; Pati HP; Bansal D; Sharma RK; Jain S
Indian J Hematol Blood Transfus; 2014 Sep; 30(Suppl 1):212-4. PubMed ID: 25332581
[TBL] [Abstract][Full Text] [Related]
35. Utility of quantitative flow cytometry immunophenotypic analysis of CD5 expression in small B-cell neoplasms.
Challagundla P; Jorgensen JL; Kanagal-Shamanna R; Gurevich I; Pierson DM; Ferrajoli A; Reyes SR; Medeiros LJ; Miranda RN
Arch Pathol Lab Med; 2014 Jul; 138(7):903-9. PubMed ID: 24978916
[TBL] [Abstract][Full Text] [Related]
36. CD5-positive follicular lymphoma: prognostic significance of this aberrant marker?
Mayson E; Saverimuttu J; Cartwright K
Intern Med J; 2014 Apr; 44(4):417-22. PubMed ID: 24754692
[TBL] [Abstract][Full Text] [Related]
37. CD5-positive follicular lymphoma characterized by CD25, MUM1, low frequency of t(14;18) and poor prognosis.
Miyoshi H; Sato K; Yoshida M; Kimura Y; Kiyasu J; Ichikawa A; Ishibashi Y; Arakawa F; Nakamura Y; Nakashima S; Niino D; Sugita Y; Ohshima K
Pathol Int; 2014 Mar; 64(3):95-103. PubMed ID: 24698419
[TBL] [Abstract][Full Text] [Related]
38. Mantle cell lymphoma with a unique pattern of CD5 expression: a case report with review of the literatures.
Yamada T; Goto N; Tsurumi H; Takata K; Sato Y; Yoshino T; Moriwaki H; Kito Y; Takeuchi T; Iwata H
Med Mol Morphol; 2014 Sep; 47(3):169-75. PubMed ID: 24166616
[TBL] [Abstract][Full Text] [Related]
39. Profiles of surface mosaics on chronic lymphocytic leukemias distinguish stable and progressive subtypes.
Huang PY; Kohnke P; Belov L; Best OG; Mulligan SP; Christopherson RI
J Pharm Pharm Sci; 2013; 16(2):231-7. PubMed ID: 23958192
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
